Effects of d-cycloserine on craving to alcohol cues in problem drinkers: Preliminary findings

American Journal of Drug and Alcohol Abuse

Volumn 38, Issue 1, 2012, Pages 101-107

  Hofmann, Stefan G ^a   Hüweler, Ruth ^a,b   MacKillop, James ^c   Kantak, Kathleen M ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c University of Georgia   (United States)

Author keywords

Alcohol; Cue exposure; Cue exposure training; Cue reactivity; D cycloserine; Problem drinkers

Indexed keywords

CYCLOSERINE; PLACEBO;

ADULT; ALCOHOL WITHDRAWAL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; HEART RATE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; AROUSAL; BEHAVIOR; CUES; CYCLOSERINE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; TREATMENT OUTCOME;

EID: 84857536606     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2011.600396     Document Type: Article

References (48)

1. Myers KM, Davis M. Behavioral and neural analysis of extinction. Neuron 2002; 36(4):567-584. (Pubitemid 35346753)
2. Hofmann SG. Cognitive processes during fear acquisition and extinction in animals and humans: Implications for exposure therapy of anxiety disorders. Clin Psychol Rev 2008; 28(2):199-210.
3. Walker DL, Davis M. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav 2002; 71(3):379-392. (Pubitemid 34117707)
4. Falls WA, Miserendino MJD, Davis M. Extinction of fearpotentiated startle - Blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 1992; 12(3): 854-863.
5. Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 2002; 22(6): 2343-2351. (Pubitemid 35386533)
6. Tuominen HJ, Tiihonen J, Wahlbeck K. Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis. Schizophr Res 2005; 72(2-3):225-234. (Pubitemid 39550993)
7. Laake JR, Oeksengaard AR. D-Cycloserine for Alzheimer's disease (Cochrane review). Cochrane Database Syst Rev 2002; 2:CD003153.
8. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M. Cognitive enhancers as adjuncts to psychotherapy - Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61(11):1136-1144. (Pubitemid 39463415)
9. Hofmann SG, Meuret AE, Smits JAJ, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 2006; 63(3):298-304. (Pubitemid 43345354)
10. Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P, Dadds MR. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 2008; 63(6): 544-549.
11. Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH. Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 2010; 67(4):365-370.
12. Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M, McCabe J, Peterson J, Foa EB. D-Cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 2007; 62(8):835-838. (Pubitemid 47488217)
13. Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 2008; 165(3):335-341. (Pubitemid 351704489)
14. Hoffman PL. NMDA receptors in alcoholism. Int Rev Neurobiol 2003; 56:35-82.
15. Krystal JH, Petrakis IL, Krupitsky E, Schutze C, Trevisan L, D'Souza DC. NMDA receptor antagonism and the ethanolintoxication signal - From al oholism risk to pharmacotherapy. Ann N Y Acad Sci 2003; 1003:176-184. (Pubitemid 38083055)
16. Bertotto ME, Bustos SG, Molina VA, Martijena ID. Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine. Neuroscience 2006; 142(4):979-990. (Pubitemid 44642332)
17. Vengeliene V, Kiefer F, Spanagel R. D-Cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats. Alcohol Alcohol 2008; 43(6):626-629.
18. Groblewski PA, Lattal KM, Cunningham CL. Effects of d-cycloserine on extinction and reconditioning of ethanolseeking behavior in mice. Alcohol Clin Exp Res 2009; 33(5):772-782.
19. Krystal JH, Petrakis IL, Limoncelli D, Nappi SK, Trevisan L, Pittman B, D'Souza DC. Characterization of the interactive effects of glycine and D-cycloserine in men: Further evidence for enhanced NMDA receptor function associated with human alcohol dependence. Neuropsychopharmacology 2011; 36(3):701-710.
20. Trevisan L, Petrakis IL, Pittman B, Gueorguieva R, D'Souza DC, Perry E, Limoncelli D, Krystal JH. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: Preliminary insights into ethanol actions at the glycine(B) site of NMDA glutamate receptors. Alcohol Clin Exp Res 2008; 32(1):36-42. (Pubitemid 350293890)
21. Bienkowski P, Stefanski R, Kostowski W. Discriminative stimulus effects of ethanol: Lack of antagonism with N-methyl-D-aspartate and D-cycloserine. Alcohol 1997; 14(4):345-350. (Pubitemid 27271061)
22. Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with Dcycloserine. CNS Drug Rev 2006; 12(3-4):208-217. (Pubitemid 46047788)
23. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of Dcycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry 2008; 63(12):1118-1126.
24. Botreau F, Paolone G, Stewart J. D-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. Behav Brain Res 2006; 172(1):173-178. (Pubitemid 44037823)
25. Kelley JB, Anderson KL, Itzhak Y. Long-term memory of cocaine-associated context: Disruption and reinstatement. NeuroReport 2007; 18(8):777-780. (Pubitemid 46686026)
26. Paolone G, Botreau F, Stewart J. The facilitative effects of d-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement. Psychopharmacology 2009; 202(1-3):403-409.
27. Thanos PK, Bermeo C,Wang GJ, Volkow ND. D-Cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice. Behav Brain Res 2009; 199(2):345-349.
28. Torregrossa MM, Sanchez H, Taylor JR. D-Cycloserine reduces the context specificity of Pavlovian extinction of cocaine cues through actions in the nucleus accumbens. J Neurosci 2010; 30(31):10526-10533.
29. Nic Dhonnchadha BA, Szalay JJ, Achat-Mendes C, Platt DM, Otto MW, Spealman RD, Kantak KM. D-Cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology 2010; 35(2):357-367.
30. Santa Ana EJ, Rounsaville BJ, Frankforter TL, Nich C, Babuscio T, Poling J, Gonsai K, Hill KP, Carroll KM. D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: A pilot investigation. Drug Alcohol Depend 2009; 104(3):220-227.
31. Price KL, McRae-Clark AL, Saladin ME, Maria MM, DeSantis SM, Back SE, Brady KT. D-Cycloserine and cocaine cue reactivity: Preliminary findings. Am J Drug Alcohol Abuse 2009; 35(6):434-438.
32. Glautier S, Drummond DC. Alcohol dependence and cue reactivity. J Stud Alcohol 1994; 55(2):224-229. (Pubitemid 24080096)
33. Babor TF, Higgins-Biddle J, Saunders JB, Monteiro MG. AUDIT: The Alcohol Use Disorders Identification Test, Guidelines for Use in Primary Care (2 ed.). Geneva: World Health Organization, 2001.
34. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID-I/P W/PSY SCREEN). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
35. Monti PM, Binkoff JA, Zwick WR, Abrams DB, Nirenberg TD, Liepman MR. Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 1987; 96(2):122-126. (Pubitemid 17085618)
36. MacKillop J. Factor structure of the Alcohol Urge Questionnaire under neutral conditions and during a cue-elicited urge state. Alcohol Clin Exp Res 2006; 30(8):1315-1321. (Pubitemid 44114682)
37. MacKillop J, Lisman SA. Effects of a context shift and multiple context extinction on reactivity to alcohol cues. Exp Clin Psychopharmacol 2008; 16(4):322-331.
38. MacKillop J, Lisman SA. Reactivity to alcohol cues: Isolating the role of perceived availability. Exp Clin Psychopharmacol 2005; 13(3):229-237. (Pubitemid 41330636)
39. MacKillop J, Lisman SA. Reactivity to alcohol cues: Refining the role of availability. Addict Res Theory 2007; 15:231-245.
40. Rohsenow DJ, Monti PM, Abrams DB, Rubonis AV, Niaura RS, Sirota AD, Colby SM. Cue elicited urge to drink and salivation in alcoholics - relationship to individual-differences. Adv Behav Res Ther 1992; 14(3):195-210.
41. D'Souza DC, Gil R, Cassello K, Morrissey K, Abi-Saab D, White J, Sturwold R, Bennett A, Karper LP, Zuzarte E, Charney DS, Krystal JH. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans. Biol Psychiatry 2000; 47(5):450-462. (Pubitemid 30110616)
42. Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with Dcycloserine. CNS Drug Rev 2006; 12(3-4):208-217. (Pubitemid 46047788)
43. Miranda R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J. Effects of topiramate on urge to drink and the subjective effects of alcohol: A preliminary laboratory study. Alcohol Clin Exp Res 2008; 32(3):489-497. (Pubitemid 351300992)
44. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol 2000; 109(4):738-742. (Pubitemid 32096235)
45. Reissner KJ, Kalivas PW. Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol 2010; 21(5-6):514-522.
46. Kalivas PW, Volkow ND. The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 2005; 162(8):1403-1413. (Pubitemid 41105554)
47. McGaugh JL, Roozendaal B. Drug enhancement of memory consolidation: Historical perspective and neurobiological implications. Psychopharmacology (Berl) 2009; 202(1-3): 3-14.
48. Carter BL, Tiffany ST. Meta-analysis of cue-reactivity in addiction research. Addiction 1999; 94(3):327-340. (Pubitemid 29137413)